SFG
AMPH icon

Steward Financial Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Steward Financial Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$0 Buy
+11
New +$600 ﹤0.01% 1323
2023
Q2 		– Sell
-6
Closed – – 446
2023
Q1 		$0 Buy
6
+5
+500% +$164 ﹤0.01% 710
2022
Q4 		$0 Buy
+1
New +$29 ﹤0.01% 535

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Steward Financial Group's AMPH Position: Q3 2023 in Review

Steward Financial Group opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2023: 11 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1323 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in AMPH as recently as Q1 2023.

Steward Financial Group first reported a position in AMPH in Q4 2022 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold AMPH as of Q3 2023.

  • Steward Financial Group held 11 shares of Amphastar Pharmaceuticals worth $0 as of Q3 2023.
  • Amphastar Pharmaceuticals was a new Steward Financial Group position in Q3 2023.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #1323 holding.
  • Steward Financial Group first reported a position in Amphastar Pharmaceuticals in Q4 2022 and has held it in 3 quarters since.
  • 256 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.